Ben obtained his medical degree from the University of Vermont College of Medicine and graduated from the Neuroscience Research Track in Psychiatry at the Yale School of Medicine in 2015, followed by a two-year research fellowship at the National Center for PTSD. Presently, he holds the position of Assistant Professor in the Department of Psychiatry at the Yale University School of Medicine. Ben spearheads a research program dedicated to exploring the therapeutic potential of psychedelic medicines for various psychiatric conditions. Additionally, he serves as the Co-Director of the Yale Program for Psychedelic Sciences.

Science, Medicine, and Psychedelics

Emerging indications for psychedelic therapies

In the last fifteen years, psychedelics have been primarily investigated for treatment of depression, anxiety, and PTSD. More recently, research programs are exploring psychedelic therapies for other psychological and neurological disorders and illnesses, including obsessive compulsive disorder, Alzheimer’s disease, Lyme disease, adjustment disorder, and eating disorders. Join us to learn more about the new frontiers of clinical applications for psychedelics.